Evidence map›Paper›PMID 37686141›Full record

ArticleInternational journal of molecular sciences2023

ERAP1 and ERAP2 Haplotypes Influence Suboptimal HLA-B*27:05-Restricted Anti-Viral CD8+ T Cell Responses Cross-Reactive to Self-Epitopes.

Valentina Tedeschi, Giorgia Paldino, Josephine Alba, Emanuele Molteni, Fabiana Paladini, Rossana Scrivo, Mattia Congia, Alberto Cauli, Rosalba Caccavale, Marino Paroli and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Valentina TedeschiDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.
Giorgia PaldinoDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.
Josephine AlbaDepartment of Biology, University of Fribourg, Chemin du Musée, 1700 Fribourg, Switzerland.ORCID 0000-0002-5467-4751
Emanuele MolteniRheumatology Unit, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.
Fabiana PaladiniDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-1040-452X
Rossana ScrivoRheumatology Unit, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-2889-8962
Mattia CongiaRheumatology Unit, AOU and University of Cagliari, 09042 Monserrato, Italy.
Alberto CauliRheumatology Unit, AOU and University of Cagliari, 09042 Monserrato, Italy.
Rosalba CaccavaleDepartment of Biotechnology and Medical Surgical Sciences, Division of Clinical Immunology and Rheumatology, Sapienza University of Rome c/o Polo Pontino, 04100 Latina, Italy.
Marino ParoliDepartment of Biotechnology and Medical Surgical Sciences, Division of Clinical Immunology and Rheumatology, Sapienza University of Rome c/o Polo Pontino, 04100 Latina, Italy.ORCID 0000-0001-7919-9128
Manuela Di FrancoRheumatology Unit, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-5468-2065
Loretta TuostoDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-9056-4077
Rosa SorrentinoDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-9632-2383
Marco D'AbramoDepartment of Chemistry, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-6020-8581
Maria Teresa FiorilloDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-6859-5851
Sapienza University of Rome · ITPoliclinico Umberto I · ITUniversity of Cagliari · ITUniversity of Fribourg · CH

Funding

Ceschina Foundation 2.Sapienza University of Rome 1.
6 · The paper itself

Abstract

The human leukocyte antigen (HLA)-B*27 family of alleles is strongly associated with ankylosing spondylitis (AS), a chronic inflammatory disorder affecting the axial and peripheral joints, yet some HLA-B*27 variants not associated with AS have been shown. Since no major differences in the ligandome of associated compared to not-associated alleles have emerged, a plausible hypothesis is that the quantity rather than the quality of the presented epitopes makes the difference. In addition, the Endoplasmic Reticulum AminoPeptidases (ERAPs) 1 and 2, playing a crucial role in shaping the HLA class I epitopes, act as strong AS susceptibility factors, suggesting that an altered peptidome might be responsible for the activation of pathogenic CD8+ T cells. In this context, we have previously singled out a B*27:05-restricted CD8+ T cell response against pEBNA3A (RPPIFIRRL), an EBV peptide lacking the B*27 classic binding motif. Here, we show that a specific ERAP1/2 haplotype negatively correlates with such response in B*27:05 subjects. Moreover, we prove that the B*27:05 allele successfully presents peptides with the same suboptimal N-terminal RP motif, including the self-peptide, pDYNEIN (RPPIFGDFL). Overall, this study underscores the cooperation between the HLA-B*27 and ERAP1/2 allelic variants in defining CD8+ T cell reactivity to suboptimal viral and self-B*27 peptides and prompts further investigation of the B*27:05 peptidome composition.

Indexed as

Genes, MHC Class ISpondylitis, AnkylosingAminopeptidasesCD8-Positive T-LymphocytesEpitopesHaplotypesHLA-B AntigensHumansMinor Histocompatibility AntigensAminopeptidasesEpitopesERAP1 protein, humanERAP2 protein, humanHLA-B AntigensMinor Histocompatibility Antigensankylosing spondylitisantigen processing and presentationanti-viral immunityCD8+ T cellsEndoplasmic Reticulum AminoPeptidase (ERAP)1 and ERAP2 haplotypeshuman leukocyte antigen (HLA)-B*27peptides

Identifiers

PMID37686141
PMCPMC10488187
OpenAlexW4386220334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.